Literature DB >> 30875431

The role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain-of-function mutation.

Catherine McLaughlin1, John Clements2, Ana-Maria Oprişoreanu3, Sergiy Sylantyev4.   

Abstract

KEY POINTS: A T258F mutation of the glycine receptor increases the receptor affinity to endogenous agonists, modifies single-channel conductance and shapes response decay kinetics. Glycine receptors of cerebellar granule cells play their functional role not continuously, but when the granule cell layer starts receiving a high amount of excitatory inputs. Despite their relative scarcity, tonically active glycine receptors of cerebellar granule cells make a significant impact on action potential generation and inter-neuronal crosstalk, and modulate synaptic plasticity in neural networks; extracellular glycine increases probability of postsynaptic response occurrence acting at NMDA receptors and decreases this probability acting at glycine receptors. Tonic conductance through glycine receptors of cerebellar granule cells is a yet undiscovered element of the biphasic mechanism that regulates processing of sensory inputs in the cerebellum. A T258F point mutation disrupts this biphasic mechanism, thus illustrating the possible role of the gain-of-function mutations of the glycine receptor in development of neural pathologies. ABSTRACT: Functional glycine receptors (GlyRs) have been repeatedly detected in cerebellar granule cells (CGCs), where they deliver exclusively tonic inhibitory signals. The functional role of this signalling, however, remains unclear. Apart from that, there is accumulating evidence of the important role of GlyRs in cerebellar structures in development of neural pathologies such as hyperekplexia, which can be triggered by GlyR gain-of-function mutations. In this research we initially tested functional properties of GlyRs, carrying the yet understudied T258F gain-of-function mutation, and found that this mutation makes significant modifications in GlyR response to endogenous agonists. Next, we clarified the role of tonic GlyR conductance in neuronal signalling generated by single CGCs and by neural networks in cell cultures and in living cerebellar tissue of C57Bl-6J mice. We found that GlyRs of CGCs deliver a significant amount of tonic inhibition not continuously, but when the cerebellar granule layer starts receiving substantial excitatory input. Under these conditions tonically active GlyRs become a part of neural signalling machinery allowing generation of action potential (AP) bursts of limited length in response to sensory-evoked signals. GlyRs of CGCs support a biphasic modulatory mechanism which enhances AP firing when excitatory input intensity is low, but suppresses it when excitatory input rises to a certain critical level. This enables one of the key functions of the CGC layer: formation of sensory representations and their translation into motor output. Finally, we have demonstrated that the T258F mutation in CGC GlyRs modifies single-cell and neural network signalling, and breaks a biphasic modulation of the AP-generating machinery.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  cerebellar granule cells; gain-of-function mutation; glycine receptor; tonic inhibitory current

Year:  2019        PMID: 30875431      PMCID: PMC6487928          DOI: 10.1113/JP277626

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  89 in total

Review 1.  Statistics of transmitter release at nerve terminals.

Authors:  M R Bennett; J L Kearns
Journal:  Prog Neurobiol       Date:  2000-04       Impact factor: 11.685

2.  M2 pore mutations convert the glycine receptor channel from being anion- to cation-selective.

Authors:  A Keramidas; A J Moorhouse; C R French; P R Schofield; P H Barry
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

3.  Subunit-specific action of an anticonvulsant thiobutyrolactone on recombinant glycine receptors involves a residue in the M2 membrane-spanning region.

Authors:  J H Steinbach; J Bracamontes; L Yu; P Zhang; D F Covey
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

4.  Distributed synaptic modification in neural networks induced by patterned stimulation.

Authors:  G Bi; M Poo
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

5.  A single beta subunit M2 domain residue controls the picrotoxin sensitivity of alphabeta heteromeric glycine receptor chloride channels.

Authors:  Q Shan; J L Haddrill; J W Lynch
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

6.  GABA concentration sets the conductance of delayed GABAA channels in outside-out patches from rat hippocampal neurons.

Authors:  B Birnir; M Eghbali; G B Cox; P W Gage
Journal:  J Membr Biol       Date:  2001-06-01       Impact factor: 1.843

7.  Pharmacological heterogeneity of gamma-aminobutyric acid receptors during development suggests distinct classes of rat cerebellar granule cells in situ.

Authors:  W Hevers; H Lüddens
Journal:  Neuropharmacology       Date:  2002-01       Impact factor: 5.250

8.  Colocalization of multiple GABA(A) receptor subtypes with gephyrin at postsynaptic sites.

Authors:  M Sassoè-Pognetto; P Panzanelli; W Sieghart; J M Fritschy
Journal:  J Comp Neurol       Date:  2000-05-15       Impact factor: 3.215

9.  The concentration of synaptically released glutamate outside of the climbing fiber-Purkinje cell synaptic cleft.

Authors:  J A Dzubay; C E Jahr
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

10.  Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance.

Authors:  S G Brickley; V Revilla; S G Cull-Candy; W Wisden; M Farrant
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

View more
  1 in total

1.  Multi-target action of β-alanine protects cerebellar tissue from ischemic damage.

Authors:  Olga Kopach; Dmitri A Rusakov; Sergiy Sylantyev
Journal:  Cell Death Dis       Date:  2022-08-29       Impact factor: 9.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.